# Efficacy and Safety of Peginterferon in ET and PV.

> **NCT06734637** · NA · RECRUITING · sponsor: **Zhenya Hong** · enrollment: 40 (estimated)

## Conditions studied

- Essential Thrombocythemia
- Polycythemia Vera

## Interventions

- **DRUG:** Peginterferon α-2b injection

## Key facts

- **NCT ID:** NCT06734637
- **Lead sponsor:** Zhenya Hong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-20
- **Primary completion:** 2026-11-20
- **Final completion:** 2027-11-20
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06734637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06734637, "Efficacy and Safety of Peginterferon in ET and PV.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06734637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*